Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4081816
Max Phase: Preclinical
Molecular Formula: C141H201N33O42S4
Molecular Weight: 3158.62
Molecule Type: Small molecule
Associated Items:
ID: ALA4081816
Max Phase: Preclinical
Molecular Formula: C141H201N33O42S4
Molecular Weight: 3158.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC2=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC1=O
Standard InChI: InChI=1S/C141H201N33O42S4/c1-18-68(9)109(168-131(205)107(142)66(5)6)133(207)159-91(51-81-55-143-64-147-81)124(198)163-98-62-218-217-61-97-125(199)150-71(12)115(189)152-86(46-65(3)4)120(194)160-94(58-175)139(213)173-44-26-33-101(173)129(203)155-87(48-78-35-39-82(180)40-36-78)117(191)145-56-103(182)166-108(67(7)8)132(206)158-90(50-80-54-144-85-31-24-23-30-84(80)85)123(197)153-88(49-79-37-41-83(181)42-38-79)122(196)162-96(126(200)151-73(14)138(212)172-43-25-32-100(172)128(202)156-89(47-77-28-21-20-22-29-77)121(195)161-95(59-176)141(215)216)60-219-220-63-99(165-134(208)110(69(10)19-2)169-137(211)113(76(17)179)170-116(190)72(13)148-114(188)70(11)149-119(193)93(53-106(186)187)154-127(98)201)140(214)174-45-27-34-102(174)130(204)157-92(52-105(184)185)118(192)146-57-104(183)167-111(74(15)177)136(210)171-112(75(16)178)135(209)164-97/h20-24,28-31,35-42,54-55,64-76,86-102,107-113,144,175-181H,18-19,25-27,32-34,43-53,56-63,142H2,1-17H3,(H,143,147)(H,145,191)(H,146,192)(H,148,188)(H,149,193)(H,150,199)(H,151,200)(H,152,189)(H,153,197)(H,154,201)(H,155,203)(H,156,202)(H,157,204)(H,158,206)(H,159,207)(H,160,194)(H,161,195)(H,162,196)(H,163,198)(H,164,209)(H,165,208)(H,166,182)(H,167,183)(H,168,205)(H,169,211)(H,170,190)(H,171,210)(H,184,185)(H,186,187)(H,215,216)/t68-,69-,70-,71-,72-,73-,74+,75+,76+,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,107-,108-,109-,110-,111-,112-,113-/m0/s1
Standard InChI Key: CBHSDJCVCHIOEA-JLYYCMRTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3158.62 | Molecular Weight (Monoisotopic): 3156.3490 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bansal PS, Smout MJ, Wilson D, Cobos Caceres C, Dastpeyman M, Sotillo J, Seifert J, Brindley PJ, Loukas A, Daly NL.. (2017) Development of a Potent Wound Healing Agent Based on the Liver Fluke Granulin Structural Fold., 60 (10): [PMID:28425707] [10.1021/acs.jmedchem.7b00047] |
Source(1):